SISTEMA CARDIOVASCULAR Y COVID-19

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know.

J Mol Cell Cardiol. 2020 Apr 24. pii: S0022-2828(20)30117-6

https://doi-org.pbidi.unam.mx:2443/10.1016/j.yjmcc.2020.04.026

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S0022282820301176?via%3Dihub#!

Endothelial cell infection and endotheliitis in COVID-19

Lancet. 2020 Apr 20. pii: S0140-6736(20)30937-5.

https://doi-org.pbidi.unam.mx:2443/10.1016/S0140-6736(20)30937-5

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S0140673620309375?via%3Dihub

COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers What Is the Evidence?

Circ Res. 2020 Apr 17.

https://doi.org/10.1161/CIRCRESAHA.120.317134

https://www.ahajournals.org/doi/abs/10.1161/CIRCRESAHA.120.317134

Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review.

J Card Surg. 2020 Apr 19.

https://doi-org.pbidi.unam.mx:2443/10.1111/jocs.14538

https://onlinelibrary-wiley-com.pbidi.unam.mx:2443/doi/full/10.1111/jocs.14538

COVID-19 and the cardiovascular system.

Nat Rev Cardiol. 2020 May;17(5):259-260.

https://doi.org/10.1038/s41569-020-0360-5

https://www-nature-com.pbidi.unam.mx:2443/articles/s41569-020-0360-5

Management of Acute Myocardial Infarction During the COVID-19 Pandemic.

J Am Coll Cardiol. 2020 Apr 18. pii: S0735-1097(20)35026-9.

https://doi-org.pbidi.unam.mx:2443/10.1016/j.jacc.2020.04.039

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S0735109720350269

Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective.

Eur Heart J. 2020 Apr 22. pii: ehaa342.

https://doi-org.pbidi.unam.mx:2443/10.1093/eurheartj/ehaa342

https://academic-oup-com.pbidi.unam.mx:2443/eurheartj/advance-article/doi/10.1093/eurheartj/ehaa342/5823766

Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response.

Curr Cardiol Rep. 2020 Apr 21;22(5):32.

https://doi.org/10.1007/s11886-020-01292-3

https://link-springer-com.pbidi.unam.mx:2443/article/10.1007%2Fs11886-020-01292-3

Cardiovascular complications in COVID-19

Am J Emerg Med. 2020 Apr 18. pii: S0735-6757(20)30277-1

https://doi-org.pbidi.unam.mx:2443/10.1016/j.ajem.2020.04.048

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S0735675720302771?via%3Dihub

Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19.

Circ Res. 2020 Apr 17.

https://doi.org/10.1161/CIRCRESAHA.120.317134

https://www.ahajournals.org/doi/abs/10.1161/CIRCRESAHA.120.317134

Angiotensin-converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS-CoV-2: A double-edged sword?

FASEB J. 2020 Apr 19.

https://doi-org.pbidi.unam.mx:2443/10.1096/fj.202000782

https://faseb-onlinelibrary-wiley-com.pbidi.unam.mx:2443/doi/full/10.1096/fj.202000782

Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin Converting Enzyme 2.

J Cardiovasc Pharmacol. 2020 Apr 13.

doi: 10.1097/FJC.0000000000000840

https://journals-lww-com.pbidi.unam.mx:2443/cardiovascularpharm/Abstract/9000/Cardiovascular_Pharmacology_in_the_Time_of.98409.aspx

Switching antihypertensive therapy in times of COVID-19: why we should wait for the evidence.

Eur Heart J. 2020 Apr 23. pii: ehaa335

https://doi-org.pbidi.unam.mx:2443/10.1093/eurheartj/ehaa335

https://academic-oup-com.pbidi.unam.mx:2443/eurheartj/advance-article/doi/10.1093/eurheartj/ehaa335/5824224

Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America.

J Card Fail. 2020 Apr 18. pii: S1071-9164(20)30367-5

https://doi-org.pbidi.unam.mx:2443/10.1016/j.cardfail.2020.04.008

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S1071916420303675?via%3Dihub

Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature.

Int J Stroke. 2020 Apr 20:1747493020921664

https://doi-org.pbidi.unam.mx:2443/10.1177%2F1747493020921664

https://journals-sagepub-com.pbidi.unam.mx:2443/doi/full/10.1177/1747493020921664?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Adapting to a novel disruptive threat: Nuclear Cardiology Service in the time of the Coronavirus (COVID-19) Outbreak 2020 (SARS REBOOT).

J Nucl Cardiol. 2020 Apr 19.

https://doi.org/10.1007/s12350-020-02117-0

https://link-springer-com.pbidi.unam.mx:2443/article/10.1007/s12350-020-02117-0

The impact of 2019 novel coronavirus on heart injury: A systemic review and Meta-analysis.

Prog Cardiovasc Dis. 2020 Apr 16. pii: S0033-0620(20)30080-3

https://doi-org.pbidi.unam.mx:2443/10.1016/j.pcad.2020.04.008

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S0033062020300803?via%3Dihub

Disruptive Modifications to Cardiac Critical Care Delivery During the Covid-19 Pandemic: An International Perspective.

J Am Coll Cardiol. 2020 Apr 14. pii: S0735-1097(20)35002-6

https://doi-org.pbidi.unam.mx:2443/10.1016/j.jacc.2020.04.029

https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S0735109720350026?via%3Dihub

Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.

Circulation. 2020 Apr 16.

https://doi.org/10.1161/CIRCULATIONAHA.120.047349

https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.120.047349

Comentarios desactivados en SISTEMA CARDIOVASCULAR Y COVID-19